Skip to main content
Evaxion biotech Logo
  • About us
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Scientific Advisors
  • AI platform technologies
  • Pipeline
    • Overview
  • Investors
    • Overview
    • Evaxion Shares
      • Share Data
      • Share Charts
      • Historical Lookup
      • Investment Calculator
      • Analyst Coverage
    • Reports & Presentations
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Financial Calendar
      • Presentations
    • Corporate Governance
      • Governance Documents
      • Committees
      • Annual Shareholder Meeting
    • Resources
      • Investor FAQs
  • News & Events
    • Press Releases
    • Events
    • Stay in Touch
  • Careers
  • Contact
    • Contact us

Site Search

Press Releases

  • About us
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Scientific Advisors
  • AI platform technologies
  • Pipeline
    • Overview
  • Investors
    • Overview
    • Evaxion Shares
      • Share Data
      • Share Charts
      • Historical Lookup
      • Investment Calculator
      • Analyst Coverage
    • Reports & Presentations
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Financial Calendar
      • Presentations
    • Corporate Governance
      • Governance Documents
      • Committees
      • Annual Shareholder Meeting
    • Resources
      • Investor FAQs
  • News & Events
    • Press Releases
    • Events
    • Stay in Touch
  • Careers
  • Contact
    • Contact us
Normal
Press release year list 2022 2021 2020 2019 2018 2017 2016
12/23/2020
Evaxion Biotech doses first patient in Phase I/IIa melanoma trial of cancer vaccine EVX-02 in combination with checkpoint inhibitors
DownloadPDF format download (opens in new window)
12/17/2020
Evaxion Biotech appoints Marianne Søgaard as Chairwoman
DownloadPDF format download (opens in new window)
12/09/2020
EU Boosts Evaxion’s Artificial Intelligence Vaccine Research
12/09/2020
Evaxion Biotech announces publication in Nature Communications describing improved selection of immunotherapy targets
10/22/2020
SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology
10/02/2020
Evaxion Biotech Launches New AI Powered Platform, RAVEN, to Enable Faster Response to Emerging Viral Pandemics
07/22/2020
Evaxion Biotech among the top 16 global companies using artificial intelligence to revolutionize drug discovery, according to experts from Frost & Sullivan
© Copyright EVAXION BIOTECH A/S - All rights reserved
Cookies Policy
Data Privacy Policy